Piper Jaffray Downgrades Horizon Pharma (HZNP) to Neutral
Tweet Send to a Friend
Piper Jaffray downgraded Horizon Pharma (NASDAQ: HZNP) from Overweight to Neutral with a price target of $9.00 (from $22.00) amid ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE